Aptose Biosciences's market cap is currently ―. The company's EPS TTM is $-0.453; its P/E ratio is -1.42; Aptose Biosciences is scheduled to report earnings on May 9, 2023, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -10.03M	$ -10.67M	$ -11.50M	$ -24.35M	$ -11.36M
EBITDA	$ -9.88M	$ -10.53M	$ -11.35M	$ -24.18M	$ -11.20M
Net Income Common Stockholders	$ -9.78M	$ -10.56M	$ -11.48M	$ -24.32M	$ -11.33M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 55.39M	$ 62.41M	$ 69.51M	$ 79.13M	$ 95.10M
Total Assets	$ 57.05M	$ 64.81M	$ 72.60M	$ 82.53M	$ 97.20M
Total Debt	$ 271.00K	$ 401.00K	$ 529.00K	$ 574.00K	$ 700.00K
Net Debt	$ -55.12M	$ -62.01M	$ -68.98M	$ -78.55M	$ -94.40M
Total Liabilities	$ 10.23M	$ 9.31M	$ 7.32M	$ 8.29M	$ 8.52M
Stockholders Equity	$ 46.81M	$ 55.49M	$ 65.28M	$ 74.24M	$ 88.68M
Cash Flow	-
Free Cash Flow	$ -6.98M	$ -7.07M	$ -9.64M	$ -16.06M	$ -8.24M
Operating Cash Flow	$ -6.98M	$ -7.05M	$ -9.64M	$ -16.04M	$ -8.06M
Investing Cash Flow	$ -5.08M	$ 10.07M	$ 7.50M	$ -20.01M	$ -185.00K
Financing Cash Flow	$ 21.00K	$ 29.00K	$ 15.00K	$ 66.00K	$ 0.00

Currency in USD

Aptose Biosciences Earnings and Revenue History

Income Statement >

Aptose Biosciences Debt to Assets

Balance Sheet >

Aptose Biosciences Cash Flow

Cash Flow >

Aptose Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing